Table 4.
ITT data set, summary statistics of fatty acid concentrations in the RBC-membrane phospholipids (RBC-FA%) of mothers and infants and in breast milk lipids (FA%) by supplement group
| Vit/Min | FOS | DHA-FOS | |
| Docosahexaenoic acid | |||
| 21 weeks' gestation | 5.76±2.45 (47) | 5.94±2.37 (48) | 5.69±2.40 (47) |
| 37 weeks' gestation | 6.93±2.32 (38) | 7.08±2.12 (36) | 8.48±2.43 (41)∗ |
| 3 months' lactation | 5.05±1.53 (27) | 5.17±2.09 (30) | 6.48±1.78 (32)∗ |
| Infant 3 months | 7.49±2.00 (16) | 6.88±2.76 (16) | 9.79±2.21 (18)∗ |
| Breast milk 3 months | 0.25±0.10 (24) | 0.26±0.13 (25) | 0.50±0.190 (29)∗∗∗ |
| Arachidonic acid | |||
| 21 weeks' gestation | 14.01±4.04 (47) | 14.82±3.60 (48) | 14.18±4.32 (47) |
| 37 weeks' gestation | 14.24±2.87 (38) | 14.47±2.72 (36) | 13.62±2.50 (41) |
| 3 months' lactation | 15.82±2.06 (27) | 15.75±2.48 (30) | 14.68±2.19 (32) |
| Infant 3 months | 17.80±2.11 (16) | 17.31±3.35 (16) | 16.09±2.04 (18) |
| Breast milk 3 months | 0.48±0.14 (24) | 0.47±0.15 (25) | 0.47±0.11 (29) |
| Eicosapentaenoic acid | |||
| 21 weeks' gestation | 0.72±0.32 (47) | 0.78±0.38 (48) | 0.79±0.41 (47) |
| 37 weeks' gestation | 0.67±0.23 (38) | 0.76±0.33 (36) | 0.99±0.36 (41)∗∗ |
| 3 months' lactation | 1.22±0.29 (27) | 1.17±0.47 (30) | 1.60±0.47 (32)∗∗ |
| Infant 3 months | 0.65±0.19 (16) | 0.71±0.40 (16) | 0.95±0.32 (18)∗∗ |
| Breast milk 3 months | 0.09±0.04 (24) | 0.09±0.06 (25) | 0.13±0.06 (29)∗ |
All values are given as mean 8 SD (n).
DHA-FOS group significantly different from Vit/Min and from FOS supplement groups. Group comparisons performed by ANCOVA, controlling for baseline values:
∗
p < 0.05;
∗∗
p < 0.005;
∗∗∗
p < 0.001.